Tower Research Capital LLC (TRC)
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,635
+$4,119 QoQ
Shares Held
23,187
+19.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $67,724,931 across 440 Biotechnology names. LCTX ranks #194 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
12,112 | $8,844,787 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,904 | $6,208,692 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,378 | $3,382,617 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,627 | $3,185,285 | |
| 5 | INSM |
INSMED Inc
|
15,410 | $2,519,843 | |
| 6 | LKFT |
Lakefront Biotherapeutics NV
|
66,536 | $1,996,080 | |
| 7 | MRNA |
Moderna, Inc.
|
33,728 | $1,713,382 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
14,349 | $1,065,556 |
All Filings in LCTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,635 | 23,187 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,516 | 19,471 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,002 | 3,552 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,059 | 27,538 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $10,487 | 23,306 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,465 | 24,930 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $11,274 | 12,390 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,177 | 31,177 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,437 | 972 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $9,053 | 8,307 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $12,196 | 10,337 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $11,245 | 7,976 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,952 | 9,968 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $13,272 | 11,344 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $341 | 302 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $319 | 202 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $12,152 | 7,891 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $19,128 | 7,808 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $9,189 | 3,647 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $24,552 | 8,615 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $470 | 200 | Shares | Other | 2021-05-17 | |
| 2020-09-30 | $14,405 | 15,325 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $35,886 | 41,249 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||